Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

Saved in:
Bibliographic Details
Title: Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Authors: Pender MP; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia m.pender@uq.edu.au., Csurhes PA; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia., Smith C; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Beagley L; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Hooper KD; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Raj M; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Coulthard A; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Burrows SR; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Khanna R; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2014 Oct; Vol. 20 (11), pp. 1541-4. Date of Electronic Publication: 2014 Feb 03.
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24493474
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pender+MP%22">Pender MP</searchLink>; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia m.pender@uq.edu.au.<br /><searchLink fieldCode="AU" term="%22Csurhes+PA%22">Csurhes PA</searchLink>; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+C%22">Smith C</searchLink>; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Beagley+L%22">Beagley L</searchLink>; QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Hooper+KD%22">Hooper KD</searchLink>; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Raj+M%22">Raj M</searchLink>; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Coulthard+A%22">Coulthard A</searchLink>; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Burrows+SR%22">Burrows SR</searchLink>; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Khanna+R%22">Khanna R</searchLink>; The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2014 Oct; Vol. 20 (11), pp. 1541-4. <i>Date of Electronic Publication: </i>2014 Feb 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24493474
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1352458514521888
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1541
    Titles:
      – TitleFull: Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pender MP
      – PersonEntity:
          Name:
            NameFull: Csurhes PA
      – PersonEntity:
          Name:
            NameFull: Smith C
      – PersonEntity:
          Name:
            NameFull: Beagley L
      – PersonEntity:
          Name:
            NameFull: Hooper KD
      – PersonEntity:
          Name:
            NameFull: Raj M
      – PersonEntity:
          Name:
            NameFull: Coulthard A
      – PersonEntity:
          Name:
            NameFull: Burrows SR
      – PersonEntity:
          Name:
            NameFull: Khanna R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2014 Oct
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1